Chronic Osteomyelitis caused by Staphylococcus Aureus: Controlled Clinical Trial of Nafcillin Therapy and Nafcillin-Rifampin Therapy

Carl W. Norden*, Richard Bryant, Darwin Palmer, John Z. Montgomerie, Joseph Wheat, Steve M. Jones, Charles B. Bird, Alan I. Hartstein, Robert C. Moellering, Adolf W. Karchmer, Robert C. Aber, Robert Greer, Monto Ho, Allen J. Weinstein, John P. Phair, Merle A. Sande, Gerald L. Mandell, Joshua Fierer, Dale Daniel, William A. CraigJon T. Mader, James A. Reinarz, Chronic Staphylococcal Osteomyelitis Study Group The Chronic Staphylococcal Osteomyelitis Study Group

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Chronic Osteomyelitis caused by Staphylococcus Aureus: Controlled Clinical Trial of Nafcillin Therapy and Nafcillin-Rifampin Therapy'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology